RBC Capital upgrades Reckitt to ‘outperform’

by | May 18, 2022

RBC Capital Markets upgraded Reckitt Benckiser on Wednesday to ‘outperform’ from ‘sector perform’ and lifted the price target to 7,000p from 5,900p.
“The re-weighting of revenue investment in favour of R&D at the expense of marketing should work well and stimulates our belief in Reckitt’s revenue growth potential,” RBC said.

“We have long believed that Reckitt over-innovates, rolling out and charging more for ‘new’ products that offered little incremental benefit. We welcome the increased emphasis on what we trust is substantive innovation, and expect it to have favourable implications for sales growth.”

The bank added that the disposal of the remaining infant nutrition business would reinforce its belief further.

At 1125 BST, the shares were up 1.7% at 6,396p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x